Maryam Dourandeesh
Overview
Explore the profile of Maryam Dourandeesh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
23
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nemati S, Saberi A, Arzpeyma S, Akbarpour M, Faghih Habibi A, Darini A, et al.
Indian J Otolaryngol Head Neck Surg
. 2025 Mar;
77(2):943-948.
PMID: 40070731
The main etiology of sudden sensorineural hearing loss (SSNHL) is uncertain and vascular problems have been proposed as one of the underlying factors in this disease. Patients with SSNHL and...
2.
Behboudi H, Alizadeh Y, Dourandeesh M, Sanaye Abbasi A, Najibzadeh E, Nabavi A
J Curr Ophthalmol
. 2024 Nov;
36(1):107-110.
PMID: 39553328
Purpose: To report two cases of diffuse unilateral subacute neuroretinitis (DUSN) from northern Iran and to present the sequential imaging. Methods: Two patients with large subretinal nematodes were evaluated and...
3.
Akbarpour M, Jalali M, Alizadeh Y, Nemati S, Akbari M, Dourandeesh M
Laryngoscope
. 2024 Oct;
135(2):E11-E12.
PMID: 39377180
No abstract available.
4.
Karkhaneh R, Faghihi H, Riazi-Esfahani H, Abrishami M, Bazvand F, Ebrahimiadib N, et al.
Ophthalmol Retina
. 2024 Mar;
8(8):744-753.
PMID: 38428459
Objective: To assess the noninferiority of biosimilar aflibercept (P041, CinnaGen) to the originator aflibercept (AFL, Regeneron) in terms of efficacy, safety, and immunogenicity. Design: This was a phase Ш, 52-week,...
5.
Dourandeesh M, Akbari M, Pourramzani A, Alizadeh Y, Leili E, Shemshadi A, et al.
Int Ophthalmol
. 2024 Feb;
44(1):30.
PMID: 38329590
Purpose: To assess the correlation among cognitive impairment (CI) and the degree of diabetic retinopathy (DR). Methods: The current analytic cross-sectional study has been carried out on two hundred ten...
6.
Alizadeh Y, Dourandeesh M
J Ophthalmic Vis Res
. 2024 Jan;
18(4):441-444.
PMID: 38250232
Purpose: This study aimed to report a case of peripapillary choroidal neovascularization (CNV) with a pitchfork sign. Case Report: A young female presented with a progressive and painless visual blurring...
7.
Akbarpour M, Jalali M, Alizadeh Y, Nemati S, Akbari M, Dourandeesh M
Laryngoscope
. 2023 Nov;
134(4):1889-1893.
PMID: 37916786
Objective: To evaluate and compare choroidal thickness (CT) between patients with Meniere's disease (MD) and a control group. Methods: This case-control analytical study was conducted on 37 subjects with MD...
8.
Alizadeh Y, Moravvej Z, Soltani-Moghadam R, Dourandeesh M, Akbari M, Azaripour E, et al.
J Curr Ophthalmol
. 2023 Jan;
34(3):312-317.
PMID: 36644463
Purpose: To assess the longitudinal changes of choroidal thickness using enhanced depth imaging optical coherence tomography (EDI-OCT) during pregnancy and postpartum. Methods: The study included 23 eyes of 23 healthy...
9.
Dourandeesh M, Moeini M, Shaye Z, Shoeibi N, Hosseini S, Banaee T
Eur J Ophthalmol
. 2022 Dec;
33(3):1405-1411.
PMID: 36476066
Purpose: To evaluate changes in subfoveal choroidal thickness (SCT) in cases of tractional diabetic macular edema (DME) after pars plana vitrectomy (PPV). Methods: This prospective study included 31 eyes of...
10.
Akbari M, Dourandeesh M
Front Med (Lausanne)
. 2022 Sep;
9:877023.
PMID: 36177323
The disease 2019 (COVID-19) has become the most critical health crisis at present, and research is continued about the exact pathophysiology, presentations, and complications of this pandemic. It influences several...